Intelligent Bio Solutions (NASDAQ:INBS) Trading 4.5% Higher

Posted by Scott Moore on Apr 20th, 2024

Shares of Intelligent Bio Solutions Inc. (NASDAQ:INBS – Get Free Report) rose 4.5% during trading on Thursday . The stock traded as high as $3.28 and last traded at $2.80. Approximately 162,360 shares traded hands during trading, a decline of 94% from the average daily volume of 2,738,967 shares. The stock had previously closed at $2.68.

Intelligent Bio Solutions Trading Down 2.1 %

The company’s 50-day moving average is $4.24 and its 200 day moving average is $3.95. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.39 and a current ratio of 0.57.

Intelligent Bio Solutions (NASDAQ:INBS – Get Free Report) last announced its quarterly earnings data on Friday, February 9th. The company reported ($2.07) EPS for the quarter, beating the consensus estimate of ($3.24) by $1.17. Intelligent Bio Solutions had a negative net margin of 544.63% and a negative return on equity of 266.16%. The company had revenue of $0.76 million for the quarter. On average, analysts forecast that Intelligent Bio Solutions Inc. will post -3.67 EPS for the current year.

Institutional Trading of Intelligent Bio Solutions

A hedge fund recently bought a new stake in Intelligent Bio Solutions stock. Citadel Advisors LLC purchased a new position in Intelligent Bio Solutions Inc. (NASDAQ:INBS – Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 156,390 shares of the company’s stock, valued at approximately $53,000. Citadel Advisors LLC owned 21.48% of Intelligent Bio Solutions as of its most recent SEC filing. 32.97% of the stock is currently owned by institutional investors.

About Intelligent Bio Solutions

(Get Free Report)

Intelligent Bio Solutions Inc, a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities.